Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Deliv. 2014 Sep;21(6):487-94. doi: 10.3109/10717544.2014.886640. Epub 2014 Mar 7.

Neuroprotective study of Nigella sativa-loaded oral provesicular lipid formulation: in vitro and ex vivo study.

Author information

1
Department of Pharmacology .

Abstract

AIM:

The aim of this research was to develop proniosome (niosomes) of Nigella sativa (NS) to improve its drug release, gastrointestinal (GI) permeation and neuroprotective activity.

MATERIALS AND METHODS:

Proniosomes were prepared by thin film method using various compositions of nonionic surfactants, cholesterol, and phosphatidylcholine. The optimum influence of different formulation variables of NS such as surfactant type, phosphatidylcholine and cholesterol concentration were optimized for size and entrapment efficiency.

RESULTS AND DISCUSSION:

Results indicated that prepared niosome showed smaller size with high entrapment efficiency. The permeation enhancement ratio was found to be 2.16 in comparison to control with maximum flux value obtained was 7.23 µg/cm(2)/h for formulation NS6. The in vivo study revealed that the niosomal dispersion significantly improved neuroprotective activity in comparison to standard and control formulation.

CONCLUSION:

In conclusion, developed proniosomal formulation could be one of the promising delivery system for NS with better drug release and GI permeation profiles and improved neuroprotective activity and merits for further study.

KEYWORDS:

Lipid formulation; Nigella Sativa; neuroprotective; oral

PMID:
24601853
DOI:
10.3109/10717544.2014.886640
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center